Table 2 Factors associated with pre-treatment loss to follow-up among bacteriologically confirmed TB patients diagnosed in 21 township health centres of the Mandalay Region of Myanmar between January and June 2017
Characteristics | Total (n) | PTLFU (n (%)) | RR (95%CI) | aRR (95%CI) |
|---|---|---|---|---|
Total | 1365 | 114 (8.4) | ||
Age (years) | ||||
< 15 | 8 | 2 (25.0) | 3.0 (0.9–10.2) | 1.3 (0.3–5.4) |
15–44 | 805 | 67 (8.3) | Ref | Ref |
45–64 | 425 | 38 (8.9) | 1.1 (0.7–1.6) | 0.9 (0.6–1.4) |
≥ 65 | 127 | 7 (5.5) | 0.7 (0.3–1.4) | 0.6 (0.2–1.3) |
Gender | ||||
Male | 1018 | 86 (8.5) | Ref | Ref |
Female | 347 | 28 (8.1) | 0.9 (0.6–1.4) | 1.0 (0.65–1.55) |
Phone number | ||||
Recorded | 38 | 1 (2.6) | 0.3 (0.0–2.2) | |
Not recorded | 1327 | 113 (8.5) | Ref | |
HIV status | ||||
Positive | 71 | 13 (18.3) | 3.5 (2.0–6.1) | 2.7 (1.4–5.0) |
Negative | 1060 | 55 (5.2) | Ref | Ref |
Unknown | 234 | 46 (19.7) | 3.8 (2.6–5.5) | 4.2 (2.7–6.4) |
History of TB treatment | ||||
Yes | 110 | 22 (20.0) | 2.5 (1.6–3.9) | 1.7 (0.9–2.8) |
No | 864 | 68 (7.9) | Ref | Ref |
Unknown | 391 | 24 (6.1) | 0.8 (0.5-1.2) | 0.5 (0.3–0.8) |
Sputum result | ||||
Smear positive | 1303 | 95 (7.3) | Ref | Ref |
Smear negative Xpert positive | 62 | 19 (30.7) | 4.2 (2.8–6.4) | 2.6 (1.4–4.6) |
Site of sputum microscopy | ||||
Low volume | 308 | 11 (3.6) | Ref | Ref |
Moderate volume | 328 | 27 (8.2) | 2.3 (1.2–4.6) | 2.2 (1.1–4.4) |
High volume | 729 | 76 (10.4) | 2.9 (1.6–5.4) | 1.7 (0.9–3.2) |